Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

February is American Heart Month. It's a time dedicated to raising awareness and education about heart disease.

February is American Heart Month. It's a time dedicated to raising awareness and education about heart disease.

Heart disease is the leading cause of death in the United States, according to the National Institutes of Health. It affects ...

A new collection of articles offering expert insight and policy recommendations to tackle the national cardiovascular health ...